Health Economics Research Unit, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.
Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Pharmacoeconomics. 2020 Mar;38(3):259-267. doi: 10.1007/s40273-019-00878-2.
Decision makers increasingly require cost-effectiveness evidence to inform resource allocation and the need for systematic reviews of economic evaluations (SREEs) has grown accordingly. The objective of this article is to describe current practice and identify unique challenges in conducting and reporting SREEs. Current guideline documents for SREEs were consulted and summarised. A rapid review of English-language SREEs, using MEDLINE and EMBASE, published in 2017/2018, containing at least 20 studies was undertaken to describe current practice. Information on data extraction methods, quality assessment (QA) tools and reporting methods were narratively summarised. Lessons learned from a recently conducted SREE of weight loss interventions for severely obese adults were discussed. Sixty-three publications were included in the rapid review. Substantial heterogeneity in review methods, reporting standards and QA approaches was evident. Our recently conducted SREE on weight loss interventions identified scope to improve process efficiency, opportunity for more transparent and succinct reporting, and potential to improve consistency of QA. Practical solutions may include (1) using pre-piloted data extraction forms linked explicitly to results tables; (2) consistently reporting on key assumptions and sensitivity analyses that drive results; and (3) using checklists that include topic-specific items where relevant and allow reviewers to distinguish between reporting, justification and QA. The lack of a mutually agreed, standardised set of best practice guidelines has led to substantial heterogeneity in the conduct and reporting of SREEs. Future work is required to standardise the approach to conducting SREEs so that they can generate efficient, timely and relevant evidence to support decision-making. We suggest only data extracting information that will be reported, focusing discussion around the key drivers of cost-effectiveness, and improving consistency in QA by distinguishing between what is reported, justified by authors and deemed appropriate by the reviewer.
决策者越来越需要成本效益证据来为资源配置提供信息,因此对系统评价经济评估(SREE)的需求也相应增加。本文的目的是描述当前的实践,并确定进行和报告 SREE 时的独特挑战。咨询并总结了当前的 SREE 指南文件。对 2017/2018 年发表的至少包含 20 项研究的英语 SREE 进行了快速综述,以描述当前的实践。对数据提取方法、质量评估(QA)工具和报告方法的信息进行了叙述性总结。还讨论了最近进行的一项严重肥胖成年人减肥干预措施的 SREE 中吸取的经验教训。快速综述共纳入 63 篇文献。审查方法、报告标准和 QA 方法存在明显的异质性。我们最近进行的一项关于减肥干预措施的 SREE 发现,在提高过程效率、提高透明度和简洁性报告、提高 QA 一致性方面存在机会。实际解决方案可能包括:(1)使用与结果表明确相关联的预填数据提取表;(2)始终如一地报告影响结果的关键假设和敏感性分析;(3)使用清单,其中包括相关的主题特定项目,并允许审查员区分报告、论证和 QA。缺乏一套相互商定的、标准化的最佳实践指南,导致 SREE 的进行和报告存在很大的异质性。需要进一步的工作来标准化 SREE 的进行方法,以便它们能够生成高效、及时和相关的证据来支持决策。我们建议只提取将报告的数据,重点讨论成本效益的关键驱动因素,并通过区分报告、作者论证和审查员认为适当的内容来提高 QA 的一致性。